June 29 (Reuters) – Tiziana Existence Sciences PLC:
TIZIANA LIFE SCIENCES -AGREEMENT FOR GMP MANUFACTURING OF ANTI-INTERLEUKIN-6-RECEPTOR MONOCLONAL ANTIBODY FOR CLINICAL STUDIES IN PATIENTS WITH COVID Provide textual content for Eikon: Additional firm protection:
Our Requirements: The Thomson Reuters Trust Rules.
